Clinical and laboratory findings of spotted fever in Israeli children.
In a prospective study of 70 Israeli children with spotted fever the major clinical features were fever (100%), skin rash (98.5%), myalgia (54%) and vomiting (40%). Thrombocytopenia (75%) and hyponatremia (62.5%) were common, but were not associated with increased mortality. Antibodies to Rickettsia conorii were detected by the indirect immunofluorescent antibody assay. In one patient Rickettsia was grown from blood. Contacts with dogs were reported in 17 of 40 patients questioned, and in only 2 was a canine tick bite obvious. Hospitalization was required in 11 (16%) patients. There was 1 fatality. The rickettsia responsible for spotted fever in Israel appears to be an antigenic variant of R. conorii. Early recognition and treatment of this disease permits rapid eradication of the rickettsiae and facilitates complete recovery.
Wolach
B
B
Department of Pediatrics, Meir General Hospital, Sapir Medical Center, Kfar Saba, Israel.
Franco
S
S
Bogger-Goren
S
S
Drucker
M
M
Goldwasser
R A
RA
Sadan
N
N
Bernheim
J
J
D000907:Antibodies, Bacterial / Q000032:analysis; D001907:Boutonneuse Fever / Q000175:diagnosis*; D002648:Child; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007557:Israel; D008297:Male; D011446:Prospective Studies; D012281:Rickettsia / Q000276:immunology; D012373:Rocky Mountain Spotted Fever / Q000175:diagnosis*
D000907:Antibodies, Bacterial; D007074:Immunoglobulin G; D007075:Immunoglobulin M